Microbial Monitoring for Biopharma Manufacturing

Microbial contamination remains a persistent challenge in biopharmaceutical manufacturing, threatening product integrity, patient safety, and profitability. This article examines how manufacturers can strengthen microbial monitoring by integrating advanced detection methods such as qPCR, biosensors and next-generation sequencing into existing workflows.

By moving beyond traditional testing and embracing real-time, high-sensitivity technologies, biopharma companies can detect contamination earlier, reduce production risks, and maintain regulatory compliance. Continue reading to explore how modern microbial monitoring can transform contamination control and safeguard bioprocessing operations from start to finish.